Pacira BioSciences, Inc.

Pacira BioSciences, Inc.

PCRX·NASDAQ

$22.32

+0.31%
HealthcareDrug Manufacturers - Specialty & Generic

Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature only to targeted nerves. It also develops proprietary multivesicular liposome, a drug delivery technology that encapsulates drugs without altering their molecular structure. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.

At a Glance

Live Snapshot
Market Cap$877.96M
EPS0.1600
P/E Ratio139.50
Earnings Date08/04/2026

pcrx

Operating Expenses

Last Annual Value

543.36M

3-Year CAGR

10%

5-Year CAGR

15%

10-Year CAGR

12%

Pacira BioSciences, Inc.

Pacira BioSciences, Inc. Competitors Analysis of Operating Expenses

PCRX · NASDAQ
CompanyOperating Expenses
CAGR 3Y
CAGR 5Y
CAGR 10Y
543.36M
10.5%11.8%10.6% 
312.50M
23.0%18.4%N/A
608.97M
0.4%11.5%19.6%
ANAB logo
AnaptysBio, Inc.
NASDAQ:ANAB
184.28M
55.2%53.7%45.6%
234.39M
-2.3%-1.9%29.9%
XNCR logo
Xencor, Inc.
NASDAQ:XNCR
292.57M
-1.6%4.8%16.2%
222.20M
17.0%10.5%29.5%
145.82M
31.1%407.4%N/A
Pacira BioSciences, Inc.

Pacira BioSciences, Inc. Fair Value Envelope

PCRX · NASDAQ

Our analysis suggests that PCRX has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $22.32, this represents a potential HIDDEN relative to our calculated worth for Pacira BioSciences, Inc..

Intrinsic Value
Current Price: $22.32